Diagnostics of vitamin B-12 - Time for reflection;Diagnostik af vitamin B12-mangel - Tid til eftertanke

Ugeskrift for Laeger

Volumn 165, Issue 19, 2003, Pages 1971-1976

  Hvas, Anne Mette ^a   Ellegaard, Jørgen ^b   Nexø, Ebba ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COBALAMIN DERIVATIVE; CYANOCOBALAMIN; METHYLMALONIC ACID; HOMOCYSTEINE;

CONCENTRATION RESPONSE; CYANOCOBALAMIN DEFICIENCY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIET SUPPLEMENTATION; DISEASE MARKER; HUMAN; REVIEW; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; BLOOD; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; HOMOCYSTEINE; HUMANS; METHYLMALONIC ACID; SENSITIVITY AND SPECIFICITY; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 0037900684     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Lindenbaum J, Healton EB, Savage DG et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 1988;318:1720-8.
2. Brynskov J, Andersen K, Gimsing P et al False low serum vitamin B-12 values with radiodilution assays using blocked R-binders. Lancet 1983;1: 1104-5.
3. Stabler SP, Marcell PD, Podell ER et al. Assay of methylmalonic acid in the serum of patients with cobalamin deficiency using capillary gas chromatography-mass spectrometry. J Clin Invest 1986;77:1606-12.
4. Rasmussen K, Solid-phase sample extraction for rapid determination of methylmalonic acid in serum and urine by a stable-isotope-dilution method. Clin Chem 1989;35:260-4.
5. Rasmussen K, Moller J, Ostergaard K et al. Methylmalonic acid concentrations in serum of normal subjects: biological variability and effect of oral L-isoleucine loads before and after intramuscular administration of cobalamin. Clin Chem 1990;36:1295-9.
6. Rasmussen K. P-methylmalonat og P-homocystein: metaboliske markører for vitaminmangel. Ugeskr Læger 1996;158:3913-8.
7. Rasmussen K, Møller J, Lyngbak M et al Age- and gender-specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation. Clin Chem 1996;42:630-6.
8. Rasmussen K, Vyberg B, Pedersen KO et al, Methylmalonic acid in renal insufficiency: evidence of accumulation and implications for diagnosis of cobalamin deficiency. Clin Chem 1990;36:1523-4.
9. Carmel R. Current concepts in cobalamin deficiency. Annu Rev Med 2000;51:357-75.
10. Pennypacker LC, Allen RH, Kelly JP et al. High prevalence of cobalamin deficiency in elderly outpatients. J Am Geriatr Soc 1992;40:1197-204.
11. Joosten E, van den Berg A, Riezler R et al. Metabolic evidence that deficiencies of vitamin B-12 (cobalamin), folate, and vitamin B-6 occur commonly in elderly people. Am J Clin Nutr 1993;58:468-76.
12. Naurath HJ, Joosten E, Riezler R et al. Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations. Lancet 1995;346:85-9.
13. Hvas AM, Ellegaard J, Nexø E. Increased plasma methylmalonic acid does not predict clinical manifestations of vitamin B-12 deficiency. Arch Intern Med 2001;161:1534-41.
14. Nexø E, Hansen M, Rasmussen K et al. How to diagnose cobalamin deficiency, Scand J Clin Lab Invest Suppl 1994;219:61-76.
15. Healton EB, Savage DG, Brust JC et al. Neurologic aspects of cobalamin deficiency. Medicine (Baltimore) 1991;70:229-45.
16. Martin DC, Francis J, Protetch J et al. Time dependency of cognitive recovery with cobalamin replacement: report of a pilot study. J Am Geriatr Soc 1992;40:168-72,
17. Kristensen MO, Gulmann NC, Christensen JE et al. Serum cobalamin and methylmalonic acid in Alzheimer dementia. Acta Neurol Scand 1993; 87:475-81.
18. Clarke R, Smith AD, Jobst KA et al, Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998; 55:1449-55.
19. Levitt AJ, Karlinsky H. Folate, vitamin B12 and cognitive impairment in patients with Alzheimer's disease. Acta Psychiatr Scand 1992;86:301-5,
20. Lindenbaum J, Savage DG, Stabler SP et al. Diagnosis of cobalamin deficiency: II. Am J Hematol 1990;34:99-107.
21. Hvas AM, Ellegaard J, Nexø E. Vitamin B-12 treatment normalizes metabolic markers but has limited clinical effect: a randomized placebo-controlled study. Clin Chem 2001;47:1396-404.
22. Carmel R, Gott PS, Waters CH et al. The frequently low cobalamin levels in dementia usually signify treatable metabolic, neurologic and electrophysiologic abnormalities, Eur J Haematol 1995;54:245-53.
23. Kwok T, Tang C, Woo J et al, Randomized trial of the effect of supplementation on the cognitive function of older people with subnormal cobalamin levels. Int J Geriatr Psychiatry 1998;13:611-6.
24. Stabler SP, Allen RH, Savage DG et al. Clinical spectrum and diagnosis of cobalamin deficiency. Blood 1990;76:871-81,
25. Savage DG, Lindenbaum J, Stabler SP et al. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med 1994;96:239-46,
26. Cunha UG, Rocha FL, Peixoto JM et al. Vitamin B12 deficiency and dementia. Int Psychogeriatr 1995;7:85-8.
27. Teunisse S, Bollen AE, van Gool WA et al. Dementia and subnormal levels of vitamin B12: effects of replacement therapy on dementia. J Neurol 1996;243:522-9.
28. Eastley R, Wilcock GK, Bucks RS. Vitamin B12 deficiency in dementia and cognitive impairment: the effects of treatment on neuropsychological function. Int J Geriatr Psychiatry 2000;15:226-33.
29. Hølleland G, Schneede J, Ueland PM et al. Cobalamin deficiency in general practice. Clin Chem 1999;5:189-98.